Search research articles
Contact Us
Filters
Showing results (11-20 of 672) with videos related to
Page
of 68
Sort By:
Annals of the Rheumatic Diseases
|
June 2, 2018
Jacques FORESTIER, a visionary of the clinical epidemiology in rheumatology
Maxime Dougados
Bulletin of the NYU Hospital for Joint Diseases
|
November 1, 2011
Current therapy for seronegative arthritides (spondyloarthritis)
Maxime Dougados
Arthritis & Rheumatology (Hoboken, N.J.)
|
December 4, 2014
Reply: To PMID 24891317
Maxime Dougados
The Lancet. Rheumatology
|
March 31, 2021
Managing patients with rheumatic diseases treated with rituximab during the COVID-19 pandemic
Maxime Dougados
The Lancet. Rheumatology
|
January 17, 2024
Effective JAK inhibitor therapy in rheumatoid arthritis: can methotrexate be discontinued?
Maxime Dougados
The Journal of Rheumatology
|
June 28, 2005
Why choose hip osteoarthritis as a human model for evaluation of drugs in osteoarthritis?
Maxime Dougados
Joint Bone Spine
|
November 28, 2006
Symptomatic slow-acting drugs for osteoarthritis: what are the facts?
Maxime Dougados
Joint Bone Spine
|
July 27, 2021
How to fill the gap between clinical trials and daily practice in chronic inflammatory rheumatic diseases?
Maxime Dougados
Annals of the Rheumatic Diseases
|
December 17, 2013
Response to: 'Comorbidities in a Mexican mestizo cohort with established rheumatoid arthritis' by Vega-Morales et al
Maxime Dougados
The Journal of Rheumatology
|
November 3, 2012
A rheumatologist managing patients with rheumatoid arthritis: an artisan but also an artist!
Maxime Dougados
Page
of 68
Search research articles
Search
Showing results (11-20 of 672) with videos related to
Sort By:
Page
of 68
Annals of the Rheumatic Diseases
|
June 2, 2018
Jacques FORESTIER, a visionary of the clinical epidemiology in rheumatology
Maxime Dougados
Bulletin of the NYU Hospital for Joint Diseases
|
November 1, 2011
Current therapy for seronegative arthritides (spondyloarthritis)
Maxime Dougados
Arthritis & Rheumatology (Hoboken, N.J.)
|
December 4, 2014
Reply: To PMID 24891317
Maxime Dougados
The Lancet. Rheumatology
|
March 31, 2021
Managing patients with rheumatic diseases treated with rituximab during the COVID-19 pandemic
Maxime Dougados
The Lancet. Rheumatology
|
January 17, 2024
Effective JAK inhibitor therapy in rheumatoid arthritis: can methotrexate be discontinued?
Maxime Dougados
The Journal of Rheumatology
|
June 28, 2005
Why choose hip osteoarthritis as a human model for evaluation of drugs in osteoarthritis?
Maxime Dougados
Joint Bone Spine
|
November 28, 2006
Symptomatic slow-acting drugs for osteoarthritis: what are the facts?
Maxime Dougados
Joint Bone Spine
|
July 27, 2021
How to fill the gap between clinical trials and daily practice in chronic inflammatory rheumatic diseases?
Maxime Dougados
Annals of the Rheumatic Diseases
|
December 17, 2013
Response to: 'Comorbidities in a Mexican mestizo cohort with established rheumatoid arthritis' by Vega-Morales et al
Maxime Dougados
The Journal of Rheumatology
|
November 3, 2012
A rheumatologist managing patients with rheumatoid arthritis: an artisan but also an artist!
Maxime Dougados
Page
of 68